These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 27838299)

  • 21. Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation expressed in Purkinje cells.
    Saegusa H; Wakamori M; Matsuda Y; Wang J; Mori Y; Zong S; Tanabe T
    Mol Cell Neurosci; 2007 Feb; 34(2):261-70. PubMed ID: 17188510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.
    Wen L; Yang S; Qiao H; Liu Z; Zhou W; Zhang Y; Huang P
    Br J Pharmacol; 2005 Jul; 145(6):728-39. PubMed ID: 15880145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant role of neuronal non-N-type calcium channels in the sympathetic neurogenic contraction of rat mesenteric artery.
    Tanaka Y; Mochizuki Y; Tanaka H; Shigenobu K
    Br J Pharmacol; 1999 Dec; 128(7):1602-8. PubMed ID: 10602342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.
    Bowersox SS; Miljanich GP; Sugiura Y; Li C; Nadasdi L; Hoffman BB; Ramachandran J; Ko CP
    J Pharmacol Exp Ther; 1995 Apr; 273(1):248-56. PubMed ID: 7714772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omega-agatoxin-TK is a useful tool to study P-type Ca2+ channel-mediated changes in internal Ca2+ and glutamate release in depolarised brain nerve terminals.
    Sitges M; Galindo CA
    Neurochem Int; 2005 Jan; 46(1):53-60. PubMed ID: 15567515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spider Toxin SNX-482 Gating Modifier Spontaneously Partitions in the Membrane Guided by Electrostatic Interactions.
    Mellado G; Espinoza N; Garate JA; Neely A
    Membranes (Basel); 2022 Jun; 12(6):. PubMed ID: 35736302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Other lipopeptides.
    Takemoto JY; Ballio A
    Science; 1995 Feb; 267(5198):605. PubMed ID: 7839133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant Production, NMR Solution Structure, and Membrane Interaction of the Phα1β Toxin, a TRPA1 Modulator from the Brazilian Armed Spider
    Lyukmanova EN; Mironov PA; Kulbatskii DS; Shulepko MA; Paramonov AS; Chernaya EM; Logashina YA; Andreev YA; Kirpichnikov MP; Shenkarev ZO
    Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venom-Derived Peptides Inhibiting Voltage-Gated Sodium and Calcium Channels in Mammalian Sensory Neurons.
    Yousuf A; Sadeghi M; Adams DJ
    Adv Exp Med Biol; 2021; 1349():3-19. PubMed ID: 35138607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spider Venom: Components, Modes of Action, and Novel Strategies in Transcriptomic and Proteomic Analyses.
    Langenegger N; Nentwig W; Kuhn-Nentwig L
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31652611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Function and Therapeutic Potential of Spider Venom-Derived Cysteine Knot Peptides Targeting Sodium Channels.
    Cardoso FC; Lewis RJ
    Front Pharmacol; 2019; 10():366. PubMed ID: 31031623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-affinity blockade of neuronal N-type Ca channels by the spider toxin omega-agatoxin-IVA.
    Sidach SS; Mintz IM
    J Neurosci; 2000 Oct; 20(19):7174-82. PubMed ID: 11007873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers.
    Kim JI; Konishi S; Iwai H; Kohno T; Gouda H; Shimada I; Sato K; Arata Y
    J Mol Biol; 1995 Jul; 250(5):659-71. PubMed ID: 7623383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of P-type calcium channel gating by the spider toxin omega-Aga-IVA.
    McDonough SI; Mintz IM; Bean BP
    Biophys J; 1997 May; 72(5):2117-28. PubMed ID: 9129813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and properties of omega-agatoxin IVB, a new antagonist of P-type calcium channels.
    Adams ME; Mintz IM; Reily MD; Thanabal V; Bean BP
    Mol Pharmacol; 1993 Oct; 44(4):681-8. PubMed ID: 8232218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of ω-Agatoxin IVA in lipid membranes.
    Ryu JH; Jung HJ; Konishi S; Kim HH; Park ZY; Kim JI
    Biochem Biophys Res Commun; 2017 Jan; 482(1):170-175. PubMed ID: 27838299
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.